Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty
A Randomized Clinical Non-Inferiority Trial Comparing Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty
Tanta University
50 participants
May 23, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).
Eligibility
Inclusion Criteria4
- Age from 18 to 75 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) classification I-III.
- Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.
Exclusion Criteria8
- Known allergies to the drugs used.
- Infection at the injection site.
- Bleeding disorders.
- Recognized neuromuscular disorders.
- Opioid addiction or dependence.
- Contraindications to regional anesthesia or peripheral nerve blockade.
- Body mass index (BMI) > 40 kg/m².
- Associated decompensated cardiac, hepatic, respiratory, or renal diseases.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive a supra-iliac anterior quadratus lumborum block (SA-QLB) using 20mL of bupivacaine 0.25%.
Patients will receive an ultrasound-guided pericapsular nerve group (PENG) block using 20mL of bupivacaine 0.25%.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07606794